In hepatocellular carcinoma (HCC), CD44 also induces a mesenchymal phenotype by activating TGFβ pathway, consequently promoting cancer migration and metastasis (Mima et al., 2012). Here, TGFB1 is linked to hepatocellular carcinoma.